Ongoing project References


Michael Nauck, Anders Frid, Kjeld Hermansen, Nalini S Shah, Tsvetalina Tankova, Ismail H Mitha, Milan Zdravkovic, Maria Düring, David R Matthews, LEAD-2 Study Group (2009) Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study., Diabetes care 32(1), p. 84-90, pubmed, doi:10.2337/dc08-1355

Chun-Jun Li, Jing Li, Qiu-Mei Zhang, Lin Lv, Rui Chen, Chun-Feng Lv, Pei Yu, De-Min Yu (2012) Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity CARDIO VASCULAR DIABETOLOGY, Cardiovascular Diabetology 11, url, doi:10.1186/1475-2840-11-142

Chun-jun Li, Jing Li, Qiu-mei Zhang, Lin Lv, Rui Chen, Chun-feng Lv, Pei Yu, De-min Yu (2012) Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity., Cardiovascular diabetology 11(1), p. 142, BioMed Central, url, doi:10.1186/1475-2840-11-142

K. Hermansen, T. A. Bækdal, M. Düring, A. Pietraszek, L. S. Mortensen, H. Jørgensen, A. Flint (2013) Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, cross-over trial, Diabetes, Obesity and Metabolism 15(11), p. 1040-1048, Blackwell Publishing Ltd, url, doi:10.1111/dom.12133

Sun H. Kim, Fahim Abbasi, Cindy Lamendola, Alice Liu, Danit Ariel, Patricia Schaaf, Kaylene Grove, Vanessa Tomasso, Hector Ochoa, Yeheng V. Liu, Yii Der Ida Chen, Gerald Reaven (2013) Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes, Diabetes Care 36(10), p. 3276-3282, doi:10.2337/dc13-0354

David J. Klein, Tadej Battelino, D.J. Chatterjee, Lisbeth V. Jacobsen, Paula M. Hale, Silva Arslanian (2014) Liraglutide's Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Pediatric Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial, Diabetes Technology & Therapeutics 16(10), p. 679-687, Mary Ann Liebert, Inc. 140 Huguenot Street, 3rd Floor New Rochelle, NY 10801 USA , url, doi:10.1089/dia.2013.0366

Ping Feng, De-min Yu, Li-ming Chen, Bao-cheng Chang, Qiu-di Ji, Shu-ying Li, Mei Zhu, Sheng-hua Ding, Bao-zhen Zhang, Su-li Wang, Hong-tao Li, Jing-na Lin, Mao-jun Wang, Jian-chao Guo, Jie Liu, Zhong-dong Liu, Shen-tao Wu, Ju-hong Yang (2015) Liraglutide reduces the body weight and waist circumference in Chinese overweight and obese type 2 diabetic patients., Acta pharmacologica Sinica 36(2), p. 200-8, Nature Publishing Group, url, doi:10.1038/aps.2014.136

Kumiko Tanaka, Yoshifumi Saisho, Toshihide Kawai, Masami Tanaka, Shu Meguro, Junichiro Irie, Takatoshi Imai, Toshikatsu Shigihara, Jiro Morimoto, Ken Yajima, Yoshihito Atsumi, Izumi Takei, Hiroshi Itoh (2015) Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight/obese patients with type 2 diabetes, Endocrine Journal 62(5), p. 399-409, url, doi:10.1507/endocrj.EJ14-0602